Best Gallbladder cancer Doctors Worldwide — TOP 114

Dr. Bülent Karagöz is a top Turkish medical oncologist with over 33 years of experience of experience, specializing in tumor biology and immunotherapy.

• Head of Medical Oncology at Anadolu Medical Center
• Professor at Istanbul Okan University Faculty of Medicine
• Published over 40 papers in cancer research
• Member of the Turkish Medical Oncology Association

Specializes in gastrointestinal cancers, including gallbladder cancer, with training at Hacettepe University Cancer Institute and MD Anderson Cancer Center.

• Completed fellowship at one of Turkey's top cancer institutes
• Worked with complex cases across multiple cancer types
• Received training at prestigious MD Anderson Cancer Center
• Practices at Hisar Hospital Intercontinental – a leading medical facility

Dr. Ilker Tinay is an urological oncologist at Anadolu Medical Center. He sits on the Executive Board of the Association of Urooncology. Dr. Tinay specializes in minimally invasive surgery and neo-bladder reconstruction. He works at Anadolu, a Top 10 global hospital according to MTQUA. The center is also affiliated with Johns Hopkins Medicine.

• Member of the American College of Surgeons and European Association of Urology.
• Secretary of the Bladder Tumours Research Group.
• Winner of the Urooncology Association Scientific Research Award.
• Performs complex procedures including robotic da Vinci prostatectomy and nephrectomy.

Prof. Peker has performed over 400 pancreatic and gastric cancer surgeries, specializing in Hepatopancreatobiliary Surgery at Hisar Hospital Intercontinental.

• Trained at Mayo Clinic in Hepatopancreatobiliary Surgery
• Founder of the Hepatopancreatobiliary Surgery unit at Bakırköy Dr. Sadi Konuk Training and Research Hospital
• Specializes in gallbladder and bile duct diseases surgery
• Performed over 200 liver surgeries

Dr. Banu Atalar is a professor and radiation oncologist at Anadolu Medical Center. She is an Honorary Fellow of the American College of Radiology (H.FACR). She completed a clinical research fellowship in stereotactic radiosurgery at Stanford University. Stereotactic radiosurgery and MR-guided adaptive SRS make up 75% of her clinical practice.

• President of the Turkish Society for Radiation Oncology.
• Chair of the ESTRO National Societies Committee.
• Recipient of the ASCO International Development and Education Award.
• Author of over 70 international peer-reviewed publications.

12,000+ laparoscopic surgeries performed – Dr. Ballesta Lopez pioneered minimally invasive techniques at Centro Médico Teknon.

• 46 years of experience of experience in digestive surgery
• Specializes in liver, gallbladder, and pancreas procedures
• Founder of Dr. Ballesta Laparoscopic Center
• IFSO-accredited Center of Excellence
• Uses Da Vinci robotic assistance for precision

Dr. Huseyin Baloglu is a pathologist at Anadolu Medical Center in Turkey. He leads liquid biopsy and precision oncology services. Dr. Baloglu holds a patent for molecular diagnostics in thyroid cancer treatment. He completed training at Albert Einstein College of Medicine and Heidelberg University.

• Authored over 600 peer-reviewed publications in molecular and surgical pathology.
• Specializes in tumor biopsy, immunohistochemistry, and genetic mutation testing.
• Treats complex oncological cases, including glioblastoma and rare sarcomas.
• Works at Anadolu Medical Center, a facility affiliated with Johns Hopkins Medicine.

Dr. Pelles Sharon conducts innovative clinical research on cancer treatments, including a notable study on patient attitudes toward clinical trials.

• Specializes in a wide range of gastrointestinal cancer surgeries
• Offers advanced therapies like HIPEC and immunotherapy
• Practices at Sourasky Medical Center (Ichilov)

Prof. Zielinski founded and directed Austria's flagship Comprehensive Cancer Center Vienna, leading Europe's largest oncology department for decades. His career is dedicated to translating research into personalized patient care.

• Four decades of experience as a medical oncologist and hematologist
• Global leader in cancer immunotherapy and individualized treatment plans
• Former President of the Central European Cooperative Oncology Group (CECOG)
• Medical Director of the International Oncology Center at Wiener Privatklinik
• Published extensively in leading oncology journals worldwide

Leading expert in soft tissue and bone oncology with a distinguished career at Sourasky Medical Center.

• Specializes in gallbladder cancer treatment protocols
• Associate Professor of Oncology at Sackler Faculty of Medicine
• Member of European Society for Medical Oncology (ESMO)
• Head of Unit for Soft Tissue and Bone Oncology

Prof. Nadir Arber leads Israel's Cancer Prevention Center at Sourasky Medical Center – focusing specifically on gastrointestinal cancers like gallbladder cancer.

• Over 44 years of experience of experience treating tumors of the digestive tract
• Author of more than 300 scientific papers on cancer research
• Specializes in cancer prevention, early detection, and gene therapy
• Trained at leading institutions, including NewYork-Presbyterian Center
• Member of the European Society of Digestive Oncology and other major societies

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. Stephanie Lilianne E. Bolle is a radiation oncologist and Head of Radiation Oncology at the Quirónsalud Proton Therapy Center in Madrid. She has led the department since July 2024. The center is Spain’s first proton therapy facility.

MD, University of Liège (1998). Board certified in radiation oncology (2003). She is an active member of the European Society of Paediatric Oncology and works with its Brain Tumor Group and Radiation Oncology Working Group.

She has published more than 120 scientific articles on pediatric brain tumors, proton therapy, pediatric radiation doses, and complex radiotherapy. She takes part in international projects and clinical trials, including BIOMEDE 2 and HARMONIC. Her expertise includes proton therapy, pediatric oncology, CNS and skull base tumors in adults and children, sarcomas, and complex radiotherapy planning.

Specializes in natural and integrative cancer treatments, including mistletoe therapy and high-dose vitamin C.

• Experienced oncologist with a focus on breast cancer and precancerous conditions
• Offers hormonal and symptomatic treatment for cancer patients
• Skilled in managing complications from chemotherapy and radiation therapy
• Participated in international conferences with German doctors

Dr. Enrique Grande is a renowned medical oncologist at Hospital Ruber Internacional in Madrid. He has authored over 300 peer-reviewed scientific publications. Dr. Grande focuses on genitourinary and rare endocrine tumors. He serves as a pioneer in precision oncology and molecular profiling.

• Directs the Medical Oncology Department at QuirónSalud.
• Treats complex cases of bladder, kidney, and prostate cancers.
• Contributes to international guidelines for ESMO and ASCO.
• Leads global clinical trials to set new cancer care standards.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Prof. Sezer Sağlam specializes in gastrointestinal oncology with extensive experience in gallbladder cancer treatment at Gayrettepe Florence Nightingale Hospital.

• Professor of Medical Oncology since 2016
• Fellowship-trained at Istanbul University
• Member of ESMO, ASCO, and ENET
• Over 27 years of experience of experience in oncology

Dr. Osama Abdel Mohimen Mohamed leads the Hematology Unit at Shefaa Al Orman Oncology Hospital. He treats complex blood cancers, including leukemia, lymphoma, and myeloma. Dr. Mohamed is a member of the European Society for Medical Oncology. He also holds memberships in the American Society of Hematology and ASBMT.

• Specializes in chemotherapy, immunotherapy, and bone marrow transplantation.
• Manages aggressive acute leukemia and chronic blood disorders.
• Treats complications arising from various solid tumors.
• Works at an ESMO-accredited center that handles 6,000 patients annually.

Prof. Sefik Igdem specializes in Radiation Oncology at Gayrettepe Florence Nightingale Hospital, using advanced technologies like Truebeam STX and Halcyons.

• Board-certified radiation oncologist with extensive experience
• Specializes in head and neck cancers and prostate cancer
• Utilizes conformal treatments for precision radiation therapy
• Professor at T.R. Demiroğlu Bilim University